scholarly journals Fear of cancer recurrence and disease progression in long‐term prostate cancer survivors after radical prostatectomy: A longitudinal study

Cancer ◽  
2021 ◽  
Author(s):  
Valentin H. Meissner ◽  
Lisa Olze ◽  
Stefan Schiele ◽  
Donna P. Ankerst ◽  
Matthias Jahnen ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Longitudinal Study ◽  
Radical Prostatectomy ◽  
Cancer Survivors ◽  
Disease Progression ◽  
Cancer Recurrence ◽  
Fear Of Cancer Recurrence ◽  
Prostate Cancer Survivors ◽  
Fear Of Cancer

Fear of cancer recurrence: a significant concern among partners of prostate cancer survivors

2017 ◽  
Vol 26 (12) ◽  
pp. 2079-2085 ◽  
Author(s):  
Marieke van de Wal ◽  
Simône Langenberg ◽  
Marieke Gielissen ◽  
Belinda Thewes ◽  
Inge van Oort ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Survivors ◽  
Cancer Recurrence ◽  
Fear Of Cancer Recurrence ◽  
Prostate Cancer Survivors ◽  
Fear Of Cancer

scholarly journals Fear of cancer recurrence in prostate cancer survivors

2016 ◽  
Vol 55 (7) ◽  
pp. 821-827 ◽  
Author(s):  
Marieke van de Wal ◽  
Inge van Oort ◽  
Joost Schouten ◽  
Belinda Thewes ◽  
Marieke Gielissen ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Survivors ◽  
Cancer Recurrence ◽  
Fear Of Cancer Recurrence ◽  
Prostate Cancer Survivors ◽  
Fear Of Cancer

scholarly journals Fear of cancer recurrence across the survivorship trajectory: Results from a survey of adult long‐term cancer survivors

2019 ◽  
Vol 28 (10) ◽  
pp. 2033-2041 ◽  
Author(s):  
Heide Götze ◽  
Sabine Taubenheim ◽  
Andreas Dietz ◽  
Florian Lordick ◽  
Anja Mehnert‐Theuerkauf
Keyword(s):  
Cancer Survivors ◽  
Cancer Recurrence ◽  
Fear Of Cancer Recurrence ◽  
Fear Of Cancer

Long-term results of a phase II randomized controlled trial (RCT) of a psychological intervention (Conquer Fear) to reduce clinical levels of fear of cancer recurrence in breast, colorectal, and melanoma cancer survivors.

2017 ◽  
Vol 35 (18_suppl) ◽  
pp. LBA10000-LBA10000 ◽  
Author(s):  
Jane McNeil Beith ◽  
Belinda Thewes ◽  
Jane Turner ◽  
Jemma Gilchrist ◽  
Louise Sharpe ◽  
...  
Keyword(s):  
Cancer Survivors ◽  
Relaxation Training ◽  
Psychological Intervention ◽  
Cancer Recurrence ◽  
Post Treatment ◽  
Fear Of Cancer Recurrence ◽  
Melanoma Cancer ◽  
Clinically Significant ◽  
Fear Of Cancer

LBA10000 Background: Up to 70% of cancer survivors report clinically significant fear of cancer recurrence (FCR). This parallel RCT evaluated the impact of a psychological intervention, Conquer Fear (CF), on FCR in cancer survivors. Methods: Participants were disease-free stage I-III breast, colorectal or melanoma cancer survivors, 2 months to 5 years post-treatment, who scored above the clinical cut-off (≥13) on the FCR Inventory (FCRI) severity subscale. CF included 5 sessions incorporating attention training, detached mindfulness, challenging unhelpful metacognitions, values clarification and psycho-education. Participants were randomised to the intervention ( n= 121) or a relaxation training (RT) control arm ( n= 101) (target n= 260). The primary end-point was reduction in FCR (FCRI total) immediately after intervention completion. Follow-up assessments occurred immediately, 3- and 6-months post-treatment. Data analysis was by intention to treat. The differences in change in FCR from baseline between CF and RT and secondary outcomes were tested using independent t-tests. A difference of 14.5 points in FCR was considered clinically significant. Long-term changes in FCR and secondary outcomes were evaluated using linear regression models fitted with generalized estimating equations (GEE), adjusted for baseline FCR. Results: Reduction in FCR between baseline and immediately post-treatment was significantly more in CF participants compared to RT. (Difference in change (95% CI): -10.5 (-16.1, -4.9); p < 0.001). Greater FCR reductions were also observed amongst CF participants at 3 months (-7.6 (-13.9, -1.4), p = 0.02) and 6 months (-7.8 (-14.2, -1.4), p = 0.02) compared with RT. The pattern of change in outcomes over time was consistent between treatment groups as no significant linear trends in treatment effects over time were observed. Conclusions: Conquer Fear is a theoretically-grounded intervention to reduce FCR and its associated psychological morbidity which leads to significantly greater reductions in FCR in the first 6 months following treatment than relaxation training. Clinical trial information: ACTRN12612000404820.

scholarly journals Fear of cancer recurrence among young adult cancer survivors—exploring long-term contributing factors in a large, population-based cohort

2020 ◽  
Author(s):  
Kathrine F. Vandraas ◽  
Kristin V. Reinertsen ◽  
Cecilie E. Kiserud ◽  
Hanne C. Lie
Keyword(s):  
Young Adult ◽  
Cancer Survivors ◽  
Cancer Recurrence ◽  
Population Based ◽  
Fear Of Cancer Recurrence ◽  
Young Adult Cancer Survivors ◽  
Adult Cancer Survivors ◽  
Fear Of Cancer ◽  
Young Adult Cancer

Abstract Purpose Fear of cancer recurrence (FCR) may be debilitating, yet knowledge of FCR among the growing population of long-term young adult cancer survivors (YACS) is scarce. We explored risk of FCR and associated factors in a nation-wide, population-based cohort of YACS. Methods All 5-year survivors diagnosed at the ages of 19–39 years with breast cancer (BC), malignant melanoma (MM), colorectal cancer (CRC), leukemia (LEU), or non-Hodgkin lymphoma (NHL) between 1985 and 2009 in Norway were identified by the Cancer Registry of Norway and completed the cross-sectional comprehensive NOR-CAYACS health survey. Univariate and multivariate linear regression modeling was performed. Results In total, 936 survivors were included, with an average of 16 years since diagnoses. BC was the most prevalent cancer form (38.4%), followed by MM (24.7%), NHL (15.6%), CRC (11.8%), and LEU (9.6%). Survivors worried most about getting another cancer (74%), and (20%) reported quite a bit or a lot of FCR. BC and MM survivors had the highest FCR scores. Post-traumatic stress symptoms (PTSS) had the strongest association with FCR (Std B 0.21, p < 0.01), above demographic and clinical variables. Conclusions FCR is prevalent even among long-term YACS, including survivors of MM with favorable prognoses. Implications for Cancer Survivors Attention to ongoing risks of PTSS and FCR in this growing survivor population is warranted to optimize future survivorship care.

scholarly journals Diversity of cancer-related identities in long-term prostate cancer survivors after radical prostatectomy

BMC Cancer ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Matthias Jahnen ◽  
Eike Mynzak ◽  
Valentin H. Meissner ◽  
Stefan Schiele ◽  
Helga Schulwitz ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Radical Prostatectomy ◽  
Cancer Survivors ◽  
Cancer Survivor ◽  
Well Being ◽  
Primary Therapy ◽  
Self Perception ◽  
Term Survival ◽  
Prostate Cancer Survivors

Abstract Background Individuals affected by cancer need to integrate this experience into their personal biography as their life continues after primary therapy, leading to substantial changes in self-perception. This study identified factors uniquely associated with 5 different cancer-related identities in order to improve the understanding of how self-perception in men affected by prostate cancer is associated with certain clinical and psychosocial characteristics. Methods In this cross-sectional study, long-term prostate cancer survivors after radical prostatectomy were asked to choose one of 5 cancer-related identities that described them best. Associations with sociodemographic, clinical, and psychological variables were investigated using multivariable logistic regression. Results Three thousand three hundred forty-seven men (mean age 78.1 years) surveyed on average 15.6 years after prostatectomy were included. Most men favored the terms “someone who has had cancer” (43.9%) which was associated with a mild disease course, and “patient” (26.3%) which was associated with ongoing therapy and biochemical disease recurrence. The self-descriptions “cancer survivor” (16.8%), “cancer conqueror” (10.9%) and “victim” (2.1%) were less common. “Cancer survivor” was associated with high perceived disease severity (OR: 1.86 [1.44–2.40]). “Cancer survivor” and “cancer conqueror” were related to high benefit finding (OR: 1.89 [1.48–2.40], OR: 1.46 [1.12–1.89] respectively), and only “cancer conqueror” was associated with high well-being (OR: 1.84 [1.35–2.50]). Identification as “victim” was associated with a positive depression screening and low well-being (OR: 2.22 [1.15–4.31], OR: 0.38 [0.20–0.72] respectively) (all p < 0.05). Conclusions Although long-term survival is common among men affected by PCa, they display a large diversity in cancer-related identities, which are associated with unique clinical and psychological characteristics. These cancer-related identities and their distinctive properties are associated with psychological well-being even after a long follow-up.

Sign in / Sign up

Export Citation Format

Share Document